What is the history of Chronic Kidney Disease?

Chronic Kidney Disease (CKD) has been recognized for centuries, evolving from ancient observations of "dropsy" to a sophisticated modern understanding of nephron function and systemic health. Today, we define Chronic Kidney Disease as the gradual loss of kidney function over time, a condition that currently affects 37 members of the DiseaseMaps.org community who share their experiences to foster collective support.

How was Chronic Kidney Disease first identified?

Early medical literature often described kidney failure through the lens of "dropsy," or generalized edema. In 1827, Richard Bright, a British physician, provided the first clinical description linking proteinuria (protein in the urine) and edema to diseased kidneys, a condition later termed "Bright’s Disease." This marked the shift from viewing kidney failure as a singular symptom to recognizing it as a systemic, organ-specific pathology.

What were the major milestones in treatment?

The history of treating Chronic Kidney Disease is defined by the transition from palliative care to life-sustaining intervention. Key milestones include:

• 1943: Willem Kolff develops the first successful rotating drum artificial kidney, the precursor to modern dialysis.


• 1954: The first successful long-term kidney transplant is performed by Dr. Joseph Murray.


• 1970s: Erythropoietin (EPO) therapy is developed to treat the anemia associated with advanced Chronic Kidney Disease.


• Modern Era: The adoption of SGLT2 inhibitors and RAAS blockers has revolutionized the management of Chronic Kidney Disease, significantly slowing disease progression.

How has our understanding of Chronic Kidney Disease changed?

Modern medicine has corrected early misconceptions that often blamed kidney decline solely on "bad humors" or lifestyle choices. We now understand that Chronic Kidney Disease is frequently driven by metabolic conditions like diabetes and hypertension. Furthermore, genetic research has identified specific mutations, such as those in the APOL1 gene, which explain why certain populations face a higher risk of developing Chronic Kidney Disease. Technology, such as serum creatinine testing and eGFR (estimated Glomerular Filtration Rate) calculations, allows for precise staging of the disease long before symptoms become debilitating.

Next steps

• Consult a nephrologist to discuss your specific eGFR and stage of Chronic Kidney Disease.


• Join the 37 fellow patients at DiseaseMaps.org to share your journey and learn from others living with the condition.


• Monitor blood pressure and blood glucose levels, as these are critical to slowing the progression of Chronic Kidney Disease.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


• National Kidney Foundation (NKF)


• PubMed: "The History of Nephrology" by J. Stewart Cameron


• DiseaseMaps.org Community Data